Search Results - Helene Karcher

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma.

    Nivolumab versus Cabozantinib: Comparing Overall Survival in Metastatic Renal Cell Carcinoma. by Witold Wiecek, Helene Karcher

    Published 2016-01-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma.

    Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line tr... by Billy Amzal, Shuai Fu, Jie Meng, Johanna Lister, Helene Karcher

    Published 2017-01-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: